Heartbeam Stock Price Prediction
| BEAT Stock | USD 2.80 0.03 1.06% |
Oversold Vs Overbought
47
Oversold | Overbought |
EPS Estimate Next Quarter (0.18) | Wall Street Target Price 5 | EPS Estimate Current Quarter (0.17) |
Using Heartbeam hype-based prediction, you can estimate the value of Heartbeam from the perspective of Heartbeam response to recently generated media hype and the effects of current headlines on its competitors.
The fear of missing out, i.e., FOMO, can cause potential investors in Heartbeam to buy its stock at a price that has no basis in reality. In that case, they are not buying Heartbeam because the equity is a good investment, but because they need to do something to avoid the feeling of missing out. On the other hand, investors will often sell stocks at prices well below their value during bear markets because they need to stop feeling the pain of losing money.
Heartbeam after-hype prediction price | USD 2.8 |
There is no one specific way to measure market sentiment using hype analysis or a similar predictive technique. This prediction method should be used in combination with more fundamental and traditional techniques such as stock price forecasting, technical analysis, analysts consensus, earnings estimates, and various momentum models.
Heartbeam |
Heartbeam After-Hype Price Prediction Density Analysis
As far as predicting the price of Heartbeam at your current risk attitude, this probability distribution graph shows the chance that the prediction will fall between or within a specific range. We use this chart to confirm that your returns on investing in Heartbeam or, for that matter, your successful expectations of its future price, cannot be replicated consistently. Please note, a large amount of money has been lost over the years by many investors who confused the symmetrical distributions of Stock prices, such as prices of Heartbeam, with the unreliable approximations that try to describe financial returns.
Next price density |
| Expected price to next headline |
Heartbeam Estimiated After-Hype Price Volatility
In the context of predicting Heartbeam's stock value on the day after the next significant headline, we show statistically significant boundaries of downside and upside scenarios based on Heartbeam's historical news coverage. Heartbeam's after-hype downside and upside margins for the prediction period are 0.14 and 7.45, respectively. We have considered Heartbeam's daily market price in relation to the headlines to evaluate this method's predictive performance. Remember, however, there is no scientific proof or empirical evidence that news-based prediction models outperform traditional linear, nonlinear models or artificial intelligence models to provide accurate predictions consistently.
Current Value
Heartbeam is very risky at this time. Analysis and calculation of next after-hype price of Heartbeam is based on 3 months time horizon.
Heartbeam Stock Price Prediction Analysis
Have you ever been surprised when a price of a Company such as Heartbeam is soaring high without any particular reason? This is usually happening because many institutional investors are aggressively trading Heartbeam backward and forwards among themselves. Have you ever observed a lot of a particular company's price movement is driven by press releases or news about the company that has nothing to do with actual earnings? Usually, hype to individual companies acts as price momentum. If not enough favorable publicity is forthcoming, the Stock price eventually runs out of speed. So, the rule of thumb here is that as long as this news hype has nothing to do with immediate earnings, you should pay more attention to it. If you see this tendency with Heartbeam, there might be something going there, and it might present an excellent short sale opportunity.
| Expected Return | Period Volatility | Hype Elasticity | Related Elasticity | News Density | Related Density | Expected Hype |
0.47 | 4.65 | 0.13 | 0.02 | 6 Events / Month | 5 Events / Month | In about 6 days |
| Latest traded price | Expected after-news price | Potential return on next major news | Average after-hype volatility | ||
2.80 | 2.80 | 0.00 |
|
Heartbeam Hype Timeline
Heartbeam is currently traded for 2.80. The entity has historical hype elasticity of -0.13, and average elasticity to hype of competition of -0.02. Heartbeam is forecasted not to react to the next headline, with the price staying at about the same level, and average media hype impact volatility is over 100%. The immediate return on the next news is forecasted to be very small, whereas the daily expected return is currently at 0.47%. %. The volatility of related hype on Heartbeam is about 11957.14%, with the expected price after the next announcement by competition of 2.78. About 29.0% of the company shares are held by company insiders. The company has Price/Earnings To Growth (PEG) ratio of 1.67. Heartbeam recorded a loss per share of 0.68. The entity had not issued any dividends in recent years. Given the investment horizon of 90 days the next forecasted press release will be in about 6 days. Check out Heartbeam Basic Forecasting Models to cross-verify your projections.Heartbeam Related Hype Analysis
Having access to credible news sources related to Heartbeam's direct competition is more important than ever and may enhance your ability to predict Heartbeam's future price movements. Getting to know how Heartbeam's peers react to changing market sentiment, related social signals, and mainstream news is a great way to find investing opportunities and time the market. The summary table below summarizes the essential lagging indicators that can help you analyze how Heartbeam may potentially react to the hype associated with one of its peers.
| HypeElasticity | NewsDensity | SemiDeviation | InformationRatio | PotentialUpside | ValueAt Risk | MaximumDrawdown | |||
| FOXO | FOXO Technologies | 0.01 | 2 per month | 9.49 | 0.12 | 35.14 | (10.00) | 509.71 | |
| EUDA | EUDA Health Holdings | 0.07 | 1 per month | 6.79 | (0) | 9.70 | (10.50) | 26.33 | |
| UTRS | Minerva Surgical | 0.00 | 0 per month | 6.57 | 0.05 | 14.81 | (13.04) | 107.58 | |
| NUTX | Nutex Health | (0.42) | 9 per month | 5.38 | 0.09 | 11.24 | (9.19) | 47.75 | |
| HCTI | Healthcare Triangle | 0.04 | 4 per month | 8.92 | 0.08 | 10.34 | (18.35) | 142.49 | |
| BFRG | Bullfrog AI Holdings, | (0.08) | 5 per month | 0.00 | (0.04) | 6.72 | (7.45) | 41.78 | |
| MGRX | Mangoceuticals, Common Stock | 0.16 | 7 per month | 0.00 | (0.10) | 7.29 | (10.11) | 37.65 | |
| LIFW | MSP Recovery | (0.12) | 8 per month | 0.00 | (0.26) | 9.88 | (14.04) | 40.15 | |
| HLTH | Cue Health | (0.01) | 6 per month | 0.00 | (0.18) | 24.48 | (29.77) | 112.25 |
Heartbeam Additional Predictive Modules
Most predictive techniques to examine Heartbeam price help traders to determine how to time the market. We provide a combination of tools to recognize potential entry and exit points for Heartbeam using various technical indicators. When you analyze Heartbeam charts, please remember that the event formation may indicate an entry point for a short seller, and look at other indicators across different periods to confirm that a breakdown or reversion is likely to occur.| Cycle Indicators | ||
| Math Operators | ||
| Math Transform | ||
| Momentum Indicators | ||
| Overlap Studies | ||
| Pattern Recognition | ||
| Price Transform | ||
| Statistic Functions | ||
| Volatility Indicators | ||
| Volume Indicators |
About Heartbeam Predictive Indicators
The successful prediction of Heartbeam stock price could yield a significant profit to investors. But is it possible? The efficient-market hypothesis suggests that all published stock prices of traded companies, such as Heartbeam, already reflect all publicly available information. This academic statement is a fundamental principle of many financial and investing theories used today. However, the typical investor usually disagrees with a 'textbook' version of this hypothesis and continually tries to find mispriced stocks to increase returns. We use internally-developed statistical techniques to arrive at the intrinsic value of Heartbeam based on analysis of Heartbeam hews, social hype, general headline patterns, and widely used predictive technical indicators.
We also calculate exposure to Heartbeam's market risk, different technical and fundamental indicators, relevant financial multiples and ratios, and then comparing them to Heartbeam's related companies. | 2017 | 2018 | 2023 | 2024 (projected) | Payables Turnover | 8.65 | 8.21 | 9.44 | 8.48 | Days Of Inventory On Hand | 17.01 | 17.94 | 16.15 | 13.47 |
Story Coverage note for Heartbeam
The number of cover stories for Heartbeam depends on current market conditions and Heartbeam's risk-adjusted performance over time. The coverage that generates the most noise at a given time depends on the prevailing investment theme that Heartbeam is classified under. However, while its typical story may have numerous social followers, the rapid visibility can also attract short-sellers, who usually are skeptical about Heartbeam's long-term prospects. So, having above-average coverage will typically attract above-average short interest, leading to significant price volatility.
Contributor Headline
Latest Perspective From Macroaxis
Heartbeam Short Properties
Heartbeam's future price predictability will typically decrease when Heartbeam's long traders begin to feel the short-sellers pressure to drive the price lower. The predictive aspect of Heartbeam often depends not only on the future outlook of the potential Heartbeam's investors but also on the ongoing dynamics between investors with different trading styles. Because the market risk indicators may have small false signals, it is better to identify suitable times to hedge a portfolio using different long/short signals. Heartbeam's indicators that are reflective of the short sentiment are summarized in the table below.
| Common Stock Shares Outstanding | 20.3 M | |
| Cash And Short Term Investments | 16.2 M |
Additional Tools for Heartbeam Stock Analysis
When running Heartbeam's price analysis, check to measure Heartbeam's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Heartbeam is operating at the current time. Most of Heartbeam's value examination focuses on studying past and present price action to predict the probability of Heartbeam's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Heartbeam's price. Additionally, you may evaluate how the addition of Heartbeam to your portfolios can decrease your overall portfolio volatility.